We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+7.28%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.08%
AUM
$42.5B
AUM Growth
+$2.36B
(+5.9%)
Cap. Flow
-$129M
Cap. Flow
% of AUM
-0.3%
Top 10 Holdings %
Top 10 Hldgs %
33.33%
Holding
1,050
New
87
Increased
310
Reduced
398
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$78.2M |
| 2 |
Amazon
AMZN
|
+$74.6M |
| 3 |
Cisco
CSCO
|
+$69.3M |
| 4 |
Monster Beverage
MNST
|
+$68.9M |
| 5 |
Oracle
ORCL
|
+$67.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$449M |
| 2 |
AGN.PRA
Allergan plc
AGN.PRA
|
+$175M |
| 3 |
AutoZone
AZO
|
+$87M |
| 4 |
Varex Imaging
VREX
|
+$49M |
| 5 |
CVS Health
CVS
|
+$44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.75% |
| 2 | Consumer Discretionary | 15.19% |
| 3 | Healthcare | 12.92% |
| 4 | Financials | 12.83% |
| 5 | Communication Services | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Amazon
AMZN
$2.43T
| $2.19B | 5.14% |
45,153,720
+1,563,480
| +4% | +$74.6M |
|
2
Meta Platforms (Facebook)
META
$1.48T
| $2.02B | 4.75% |
13,364,803
+423,475
| +3% | +$63M |
|
3
Alibaba
BABA
$276B
| $1.79B | 4.21% |
12,687,045
+315,803
| +3% | +$39M |
|
|
4
Oracle
ORCL
$339B
| $1.45B | 3.41% |
28,858,635
+1,489,395
| +5% | +$67.9M |
|
|
5
Visa
V
$703B
| $1.4B | 3.3% |
14,957,370
+842,112
| +6% | +$78.2M |
|
|
6
Cisco
CSCO
$443B
| $1.31B | 3.08% |
41,799,721
+2,128,045
| +5% | +$69.3M |
|
|
7
Monster Beverage
MNST
$95.2B
| $1.1B | 2.58% |
44,102,726
+2,859,852
| +7% | +$68.9M |
|
8
Autodesk
ADSK
$51.8B
| $1.03B | 2.43% |
10,253,764
+638,263
| +7% | +$63.2M |
|
9
Qualcomm
QCOM
$165B
| $967M | 2.28% |
17,511,227
+914,118
| +6% | +$51.1M |
|
10
Alphabet (Google) Class A
GOOGL
$4.11T
| $914M | 2.15% |
19,655,740
+404,800
| +2% | +$18.9M |
|
11
Regeneron Pharmaceuticals
REGN
$73.1B
| $895M | 2.11% |
1,822,296
+98,813
| +6% | +$43.2M |
|
|
12
Alphabet (Google) Class C
GOOG
$4.1T
| $861M | 2.03% |
18,953,380
+412,360
| +2% | +$18.9M |
|
|
NVO
13
Novo Nordisk
NVO
$228B
| $860M | 2.02% |
40,112,470
+2,116,582
| +6% | +$42.7M |
|
14
Expeditors International
EXPD
$22.3B
| $842M | 1.98% |
14,903,787
+942,403
| +7% | +$51.9M |
|
15
Procter & Gamble
PG
$341B
| $841M | 1.98% |
9,649,349
+647,639
| +7% | +$57.1M |
|
16
Coca-Cola
KO
$385B
| $831M | 1.96% |
18,531,047
+266,660
| +1% | +$11.8M |
|
17
SEI Investments
SEIC
$12.3B
| $818M | 1.92% |
15,201,500
+990,906
| +7% | +$51.1M |
|
18
Microsoft
MSFT
$2.9T
| $806M | 1.9% |
11,695,334
+274,342
| +2% | +$18.8M |
|
19
Deere & Co
DE
$165B
| $769M | 1.81% |
6,223,507
+362,841
| +6% | +$42.6M |
|
20
Bristol-Myers Squibb
BMY
$129B
| $737M | 1.73% |
13,218,225
+65,794
| +0.5% | +$3.58M |
|
|
VAR
21
DELISTED
Varian Medical Systems, Inc.
VAR
| $701M | 1.65% |
6,791,268
+409,501
| +6% | +$39.4M |
|
|
CERN
22
DELISTED
Cerner Corp
CERN
| $670M | 1.58% |
10,074,401
+535,390
| +6% | +$34.2M |
|
23
United Parcel Service
UPS
$89.1B
| $648M | 1.52% |
5,855,256
+308,886
| +6% | +$33M |
|
24
Novartis
NVS
$302B
| $554M | 1.3% |
7,400,880
+435,657
| +6% | +$30.9M |
|
25
Amgen
AMGN
$209B
| $549M | 1.29% |
3,187,646
+177,760
| +6% | +$28.9M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2017 Portfolio in Review
As of Q2 2017, Loomis, Sayles & Company held 1,050 positions worth $42.5B, up 5.9% from $40.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Loomis, Sayles & Company's Q2 2017 filing shows 87 new, 310 increased, 398 reduced and 100 closed positions. Its largest new stake was Danaher: 762,466 shares worth $57M. The largest sale was Intel, an estimated $449M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Loomis, Sayles & Company's largest Q2 2017 buy was Danaher: 762,466 shares worth $57M.
- Loomis, Sayles & Company added most to Visa in Q2 2017, an estimated $78.2M increase.
- Loomis, Sayles & Company's biggest Q2 2017 reduction was Allergan plc, cutting an estimated $175M.
- Loomis, Sayles & Company fully exited Intel in Q2 2017, selling an estimated $449M.
- Loomis, Sayles & Company's ten largest holdings make up 33% of its $42.5B portfolio in Q2 2017.
- Loomis, Sayles & Company opened 87 new positions and closed 100 in Q2 2017.
- Loomis, Sayles & Company's portfolio value rose 5.9% quarter-over-quarter to $42.5B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2017, filed 14 Aug 2017.